Status:
COMPLETED
Real Life Long-term Adherence to Ticagrelor After PCI for Acute Coronary Syndromes
Lead Sponsor:
IHF GmbH - Institut für Herzinfarktforschung
Conditions:
Acute Coronary Syndrome (ACS)
Eligibility:
All Genders
18+ years
Brief Summary
Documentation of long-term data regarding ticagrelor use and evaluation of reasons for discontinuation of ticagrelor in patients with ACS
Detailed Description
REAL-TICA is a retrospective non-interventional study to assess the long-term use of ticagrelor in patients with ACS and to evaluate the reasons for discontinuation of ticagrelor. For this purpose, s...
Eligibility Criteria
Inclusion
- Age \> 18
- ACS (STEMI or NSTE-ACS) with PCI
- Ticagrelor treatment during the acute phase
- Written informed consent for participation in the study.
Exclusion
- None
Key Trial Info
Start Date :
August 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT02265068
Start Date
August 1 2014
End Date
December 1 2016
Last Update
June 14 2018
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Zentralklinik Bad Berka GmbH
Bad Berka, Germany, 99437
2
Vivantes-Klinikum Neukölln
Berlin, Germany, 12351
3
Klinikum Hildesheim GmbH
Hildesheim, Germany, 31135
4
Krankenhaus Landshut-Achdorf
Landshut, Germany, 84036